Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Endometrial Neoplasms × Sevoflurane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Postoperative Complications 1 Neoplasms 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Agnosia 1

Interventions

pembrolizumab 3 NVP-BKM120 2 trastuzumab duocarmazine 1 talazoparib 1 sitravatinib 1 ponatinib 1 mirvetuximab soravtansine 1 lenvatinib 1 dostarlimab 1 dactolisib 1 Trastuzumab 1 Taxes 1 TAS-116 1 Sevoflurane 1 Radiotherapy 1 Propofol 1 Proflavine 1 Polymerase Chain Reaction 1 Paclitaxel 1 PM 01183 1 Methods 1 Metformin 1 Megestrol Acetate 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Interviews as Topic 1 Gene Expression Profiling 1 FP-1039 1 Educational Status 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡